Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Shaji K Kumar; Natalie S Callander; Kehinde Adekola; Larry D Anderson Jr; Muhamed Baljevic; Rachid Baz; Erica Campagnaro; Jorge J Castillo; Caitlin Costello; Christopher D'Angelo; Benjamin Derman; Srinivas Devarakonda; Noura Elsedawy; Alfred Garfall; Kelly Godby; Jens Hillengass; Leona Holmberg; Myo Htut; Carol Ann Huff; Malin Hultcrantz; Yubin Kang; Sarah Larson; Hans Lee; Michaela Liedtke; Thomas Martin; James Omel; Timothy Robinson; Aaron Rosenberg; Douglas Sborov; Mark A Schroeder; Daniel Sherbenou; Attaya Suvannasankha; Jason Valent; Asya Nina Varshavsky-Yanovsky; Jenna Snedeker; Rashmi Kumar

doi:10.6004/jnccn.2024.0001

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

J Natl Compr Canc Netw. 2024 Jan;22(1D):e240001. doi: 10.6004/jnccn.2024.0001.

Authors

Shaji K Kumar¹, Natalie S Callander², Kehinde Adekola³, Larry D Anderson Jr⁴, Muhamed Baljevic⁵, Rachid Baz⁶, Erica Campagnaro⁷, Jorge J Castillo⁸, Caitlin Costello⁹, Christopher D'Angelo¹⁰, Benjamin Derman¹¹, Srinivas Devarakonda¹², Noura Elsedawy¹³, Alfred Garfall¹⁴, Kelly Godby¹⁵, Jens Hillengass¹⁶, Leona Holmberg¹⁷, Myo Htut¹⁸, Carol Ann Huff¹⁹, Malin Hultcrantz²⁰, Yubin Kang²¹, Sarah Larson²², Hans Lee²³, Michaela Liedtke²⁴, Thomas Martin²⁵, James Omel²⁶, Timothy Robinson²⁷, Aaron Rosenberg²⁸, Douglas Sborov²⁹, Mark A Schroeder³⁰, Daniel Sherbenou³¹, Attaya Suvannasankha³², Jason Valent³³, Asya Nina Varshavsky-Yanovsky³⁴, Jenna Snedeker³⁵, Rashmi Kumar³⁵

Affiliations

¹ Mayo Clinic Comprehensive Cancer Center.
² University of Wisconsin Carbone Cancer Center.
³ Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
⁴ UT Southwestern Simmons Comprehensive Cancer Center.
⁵ Vanderbilt-Ingram Cancer Center.
⁶ Moffitt Cancer Center.
⁷ University of Michigan Rogel Cancer Center.
⁸ Dana-Farber/Brigham and Women's Cancer Center.
⁹ UC San Diego Moores Cancer Center.
¹⁰ Fred & Pamela Buffett Cancer Center.
¹¹ The UChicago Medicine Comprehensive Cancer Center.
¹² The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
¹³ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
¹⁴ Abramson Cancer Center at the University of Pennsylvania.
¹⁵ O'Neal Comprehensive Cancer Center at UAB.
¹⁶ Roswell Park Comprehensive Cancer Center.
¹⁷ Fred Hutchinson Cancer Center.
¹⁸ City of Hope National Medical Center.
¹⁹ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
²⁰ Memorial Sloan Kettering Cancer Center.
²¹ Duke Cancer Institute.
²² UCLA Jonsson Comprehensive Cancer Center.
²³ The University of Texas MD Anderson Cancer Center.
²⁴ Stanford Cancer Institute.
²⁵ UCSF Helen Diller Family Comprehensive Cancer Center.
²⁶ Patient Advocate.
²⁷ Yale Cancer Center/Smilow Cancer Hospital.
²⁸ UC Davis Comprehensive Cancer Center.
²⁹ Huntsman Cancer Institute at the University of Utah.
³⁰ Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
³¹ University of Colorado Cancer Center.
³² Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
³³ Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
³⁴ Fox Chase Cancer Center.
³⁵ National Comprehensive Cancer Network.

PMID: 38244272
DOI: 10.6004/jnccn.2024.0001

Abstract

The treatment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) has evolved to include several new options. The NCCN Guidelines for WM/LPL provide a framework on which to base decisions regarding diagnosis, treatment, assessment of response to treatment, and follow-up of both newly diagnosed and previously treated WM/LPL.

Publication types

Practice Guideline

MeSH terms

Humans
Lymphoma, B-Cell*
Waldenstrom Macroglobulinemia* / drug therapy
Waldenstrom Macroglobulinemia* / therapy